12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok

allogen transplantation kan anvendes ved alder over 55 år.
Primær resistent ALL (induction failure) eller ALL i relaps
Der er ikke indikation for allogen HCT.
Referencer vedrørende HCT af ALL hos voksne
Risikofaktorer
Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A. et al (1988). Prognostic factors in a multicenter study
for treatment of acute lymphoblastic leukemia in adults. Blood, 71, 123-131.
Gleissner B, Goekbuget N, Rieder H et al (2005). CD10- pre-B acute lymphoblastic leukaemia (ALL) is a distinct
high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German
Multicenter Trials for Adult ALL (GMALL). Blood, 106, 4054-4056.
Czuczman M, Dodge R, Carleton C, Stewart RS et al (1999). Value of immunephenotype in intensively treated
adult acute lymphoblastic leukaemia: Cancer and Leukemia Group B study 8364.Blood, 93, 3931-3939.
Ferrando A, Neuberg DS, Dodge RK, Paiette E et al (2004). Prognostic importance of TLX1 (HOX11) oncogen
expression in adults with T-cell acute lymphoblasic leukaemia. Lancet, 363, 535-536.
Faderl, S., Kantarjian, H.M., Talpaz, M., and Estrov, Z (1998). Clinical significance of cytogenetic abnormalities
in adult acute lymphoblastic leukemia. Blood , 91, 3995-4019.
Wetzler M, Dodge R, Mrózek K, Carroll A et al (1999). Prospective kareotype analysis in adult ac
ute lymphoblastic leukaemia: The Cancer and Leukemia Group B experience. Blood, 93,3983-3993.
Charrin C, Thomas X, Ffrench M, Le Q-H et al (2004). A report from the LALA-94 and LALA-SA groups on
hypodiploidi with 30-39 chromosomes and near-triploidi: 2 possible expressions of a sole entity conferring poor
prognosis in adult acute lymphoblastic leukaemia (ALL). Blood,104, 2444-2451.
Harrison C, Moorman A, Broadfield Z, Cheung K et al (2004). Three distinct subgroups of hypodiploidi in acyte
lymphoblastic leukaemia. Brit J Haematol , 125, 552-559.
Lazarus H, Richards S, Chora R et al (2006): Central nervous system involvement in adult acute lymphoblastic
leukaemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E 2993. Blood, 108, 465-
472.
Bruggemann M, Raff T, Flohr T et al (2006): Clinical significans of minimal residual disease quantification in
adult patients with standard-risk acute lymphoblastic leukaemia. Blood, 107, 1116-1123.
Moorman AV, Harrison CJ, Buck GAN et al (2007): Karyotype is an independent prognostic factor in adult acute
lymphoblastic leukaemia(ALL): analysis of cytogenetic data from patients treated on the Medican Research
Council (MRC) UKALLXII/Eastern Cooporative Oncology Group (ECOG) 2993 trial. Blood, 109, 3189-3197.
Thomas DA, O’Brien S, Jorgensen JL, et al (2008): Prognostic significance of CD20 expression in adults with de
novo precursor B-lineage acute lymphoblastic leukaemia. Blood, prepublished online 14 Aug 2008.
18